NYSE •
Healthcare •
Biotechnology •
Quote as of 08/07/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization47.44 mln
Float11.49 mln
Earnings Date08/14/2026
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
19
/ 100
Significantly lagging
Debt / Equity
2.00
Very high leverage
ROE
-1,115
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Impact BioMedical Inc. is a Houston-based healthcare company founded in 2018 that researches and brings to market treatments and wellness products across areas such as antivirals, antimicrobials, and specialty pharmaceuticals. The company has developed several proprietary technologies, including compounds targeting cancer, inflammation, and neurological conditions, as well as antiviral health supplements and a sugar-based ingredient designed to reduce harmful metabolic responses. It also works with plant-derived fragrance formulations that serve as antimicrobial agents and can be added to everyday products like lotions, shampoos, and detergents. Impact BioMedical operates as a subsidiary of DSS BioHealth Security Inc.
